Journal
MUCOSAL IMMUNOLOGY
Volume 1, Issue 3, Pages 219-228Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/mi.2008.6
Keywords
-
Categories
Funding
- Public Health Services [U51RR00169]
- National Center for Research Resources
- National Institute of Allergy and Infectious Diseases [P01 AI066314, R01 AI44480]
- James B Pendleton Charitable Trust
Ask authors/readers for more resources
Live attenuated lentivirus immunization is the only vaccine strategy that elicits consistent protection against intravaginal challenge with pathogenic simian immunodeficiency virus (SIV). To determine the mechanism of protection in rhesus monkeys infected with attenuated simian-human immunodeficiency virus (SHIV)89.6,a detailed analysis of SIV Gag-specific T-cell responses in several tissues including the genital tract was performed. Six months after SHIV infection, antiviral T-cell responses were rare in the cervix; however, polyfunctional, cytokine-secreting, and degranulating SIV Gag-specific CD4(+) T cells were consistently found in the vagina of the immunized macaques. SIV-specific CD8(+) T cells were also detected in the vagina, blood, and genital lymph nodes of most of the animals. Thus, an attenuated SHIV vaccine induces persistent antiviral T cells in tissues, including the vagina, where these effector T-cell responses may mediate the consistent protection from vaginal SIV challenge observed in this model.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available